Domain created to manage non eCTD4 controlled vocabularies required to support IDMP
|
HA Controlled Vocabulary
Controlled Vocabulary / Code System Name as defoined by the Health Authority
|
Term
Term Description as defined by the Health Authority
|
Code
Code, if any, associated with the term by the Health Authority
|
Agency
Name of the issuing Health Authority (abbreviation) that maintains the term and code
|
Status
Current status of the Term usage as defined by the Health Authority (e.g., Current, Retired, Deprecated)
|
|---|---|---|---|---|
| SPL Pharmaceutical Dosage Form Terminology | GUM, CHEWING |
C42894
|
FDA | — |
| SPL Drug Route of Administration Terminology | HEMODIALYSIS |
C38200
|
FDA | — |
| SPL Business Operation Terminology | Human Drug Compounding Outsourcing Facility |
C112113
|
FDA | — |
| SPL Marketing Category Terminology | HUMANITARIAN DEVICE EXEMPTION |
C80440
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | IMPLANT |
C42942
|
FDA | — |
| SPL Business Operation Terminology | IMPORT |
C73599
|
FDA | — |
| SPL Business Operation Terminology | IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING |
C101512
|
FDA | — |
| SPL Marketing Category Terminology | IND |
C75302
|
FDA | — |
| SPL Drug Route of Administration Terminology | INFILTRATION |
C38215
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INHALANT |
C42944
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTABLE FOAM |
C113106
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTABLE, LIPOSOMAL |
C60931
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION |
C42946
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, EMULSION |
C42914
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, LIPID COMPLEX |
C42950
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, POWDER, FOR SOLUTION |
C42974
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, POWDER, FOR SUSPENSION |
C42976
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE |
C42977
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION |
C42959
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
C42957
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
C42958
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE |
C42956
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, SOLUTION |
C42945
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, SOLUTION, CONCENTRATE |
C42899
|
FDA | — |
| SPL Pharmaceutical Dosage Form Terminology | INJECTION, SUSPENSION |
C42995
|
FDA | — |
Showing 101–125 of 401 terms . Data sourced from public health authority publications and updated periodically.